Put Options

17 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$29.51 - $46.26 $239,031 - $374,706
8,100 New
8,100 $374,000
Q1 2023

May 15, 2023

BUY
$19.2 - $24.47 $203,520 - $259,382
10,600 New
10,600 $229,000
Q3 2021

Nov 12, 2021

SELL
$19.68 - $22.53 $478,224 - $547,479
-24,300 Closed
0 $0
Q2 2021

Aug 06, 2021

BUY
$19.97 - $24.43 $485,271 - $593,649
24,300 New
24,300 $540,000
Q4 2020

Feb 12, 2021

SELL
$16.78 - $27.3 $469,840 - $764,400
-28,000 Closed
0 $0
Q3 2020

Nov 13, 2020

SELL
$12.46 - $19.98 $2,492 - $3,996
-200 Reduced 0.71%
28,000 $491,000
Q2 2020

Aug 13, 2020

BUY
$11.0 - $18.26 $192,500 - $319,550
17,500 Added 163.55%
28,200 $472,000
Q1 2020

May 11, 2020

SELL
$10.11 - $14.04 $131,430 - $182,520
-13,000 Reduced 54.85%
10,700 $125,000
Q4 2019

Feb 12, 2020

SELL
$12.06 - $16.96 $43,416 - $61,056
-3,600 Reduced 13.19%
23,700 $286,000
Q3 2019

Nov 14, 2019

BUY
$10.41 - $14.66 $122,838 - $172,988
11,800 Added 76.13%
27,300 $398,000
Q2 2019

Aug 20, 2019

SELL
$9.78 - $12.76 $198,534 - $259,028
-20,300 Reduced 56.7%
15,500 $173,000
Q1 2019

May 15, 2019

SELL
$10.03 - $15.71 $239,716 - $375,469
-23,900 Reduced 40.03%
35,800 $420,000
Q4 2018

Feb 14, 2019

SELL
$11.29 - $17.19 $251,766 - $383,337
-22,300 Reduced 27.2%
59,700 $777,000
Q3 2018

Nov 14, 2018

BUY
$12.27 - $15.65 $1.01 Million - $1.28 Million
82,000 New
82,000 $1.15 Million
Q1 2018

May 15, 2018

SELL
$14.59 - $25.5 $541,289 - $946,050
-37,100 Closed
0 $0
Q4 2017

Feb 14, 2018

BUY
$15.77 - $20.72 $244,435 - $321,160
15,500 Added 71.76%
37,100 $670,000
Q3 2017

Nov 15, 2017

BUY
$12.3 - $19.3 $265,680 - $416,880
21,600
21,600 $417,000

Others Institutions Holding CORT

About CORCEPT THERAPEUTICS INC


  • Ticker CORT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 107,105,000
  • Market Cap $7.29B
  • Description
  • Corcept Therapeutics Incorporated discovers, develops, and commercializes drugs for the treatment of severe metabolic, oncologic, and neuropsychiatric disorders in the United States. The company offers Korlym (mifepristone) tablets as a once-daily oral medication for the treatment of hyperglycemia secondary to hypercortisolism in adult patients ...
More about CORT
Track This Portfolio

Track Wolverine Trading, LLC Portfolio

Follow Wolverine Trading, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wolverine Trading, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Wolverine Trading, LLC with notifications on news.